Published in Nat Commun on December 14, 2015
Neurotrophin signaling endosomes: biogenesis, regulation, and functions. Curr Opin Neurobiol (2016) 0.78
The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases. J Aging Res (2016) 0.78
There and back again: coordinated transcription, translation and transport in axonal survival and regeneration. Curr Opin Neurobiol (2016) 0.76
Phospho-Regulation of Soma-to-Axon Transcytosis of Neurotrophin Receptors. Dev Cell (2017) 0.75
Down's syndrome. Lancet (2003) 5.10
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93
Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (1994) 3.73
Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A (1994) 3.61
Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet (2004) 3.58
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron (2006) 3.51
A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell (2004) 3.38
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet (2000) 2.93
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88
Functions and mechanisms of retrograde neurotrophin signalling. Nat Rev Neurosci (2005) 2.78
Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry (1976) 2.76
A conserved family of calcineurin regulators. Genes Dev (2000) 2.65
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64
Evidence in support of signaling endosome-based retrograde survival of sympathetic neurons. Neuron (2003) 2.33
The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat Immunol (2003) 2.17
Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci (2005) 2.11
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol (2002) 2.03
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 1.95
The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med (2003) 1.80
Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology (1985) 1.75
Heterogeneous requirement of NGF for sympathetic target innervation in vivo. J Neurosci (2004) 1.74
The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J Neurosci (2009) 1.73
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A (2001) 1.72
Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell (2008) 1.72
A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet (1995) 1.68
Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics (1997) 1.68
Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet (2007) 1.57
Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J Biol Chem (2001) 1.49
Prelysosomal divergence of transferrin and epidermal growth factor during receptor-mediated endocytosis. Biochemistry (1983) 1.46
Reduced work capacity in individuals with Down syndrome: a consequence of autonomic dysfunction? Exerc Sport Sci Rev (2013) 1.46
Spatially and functionally distinct roles of the PI3-K effector pathway during NGF signaling in sympathetic neurons. Neuron (2000) 1.40
Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci U S A (2005) 1.33
Long-distance retrograde neurotrophic factor signalling in neurons. Nat Rev Neurosci (2013) 1.30
Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev Neurobiol (2007) 1.29
TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J Neurosci (1996) 1.29
Trisomy 21 and early brain development. Trends Neurosci (2011) 1.28
Axonal targeting of Trk receptors via transcytosis regulates sensitivity to neurotrophin responses. J Neurosci (2009) 1.28
The challenge of Down syndrome. Trends Mol Med (2006) 1.28
The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J Neurosci (2007) 1.26
Directed expression of NGF to pancreatic beta cells in transgenic mice leads to selective hyperinnervation of the islets. Cell (1989) 1.23
Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol (1995) 1.15
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci (2003) 1.12
Wnt5a mediates nerve growth factor-dependent axonal branching and growth in developing sympathetic neurons. J Neurosci (2009) 1.09
Neuronal signaling through endocytosis. Cold Spring Harb Perspect Biol (2014) 1.06
The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech (2011) 1.05
Developmental changes of nerve growth factor levels in sympathetic ganglia and their target organs. Dev Biol (1988) 1.05
A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J Neurosci (1997) 1.02
Endocytic trafficking of neurotrophins in neural development. Trends Cell Biol (2012) 1.01
Isoform-specific dephosphorylation of dynamin1 by calcineurin couples neurotrophin receptor endocytosis to axonal growth. Neuron (2011) 1.00
TrkA gene ablation in basal forebrain results in dysfunction of the cholinergic circuitry. J Neurosci (2012) 0.99
Differential regulation of neurotrophin expression in basal forebrain astrocytes by neuronal signals. J Neurosci Res (2004) 0.99
Protocol for culturing sympathetic neurons from rat superior cervical ganglia (SCG). J Vis Exp (2009) 0.98
Sympathetic innervation during development is necessary for pancreatic islet architecture and functional maturation. Cell Rep (2013) 0.96
Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J Biol Chem (2011) 0.94
Attenuated responses to sympathoexcitation in individuals with Down syndrome. J Appl Physiol (1985) (2003) 0.93
Is innervation an early target in autoimmune diabetes? Trends Immunol (2003) 0.92
Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice. Mamm Genome (2010) 0.91
Autonomic cardiac innervation: development and adult plasticity. Organogenesis (2013) 0.91
Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology (1998) 0.90
Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. J Ment Defic Res (1985) 0.89
Loss of NGF-TrkA signaling from the CNS is not sufficient to induce cognitive impairments in young adult or intermediate-aged mice. J Neurosci (2012) 0.89
Altered autonomic cardiac regulation in individuals with Down syndrome. Am J Physiol Heart Circ Physiol (2005) 0.85
Chronotropic incompetence in persons with down syndrome. Arch Phys Med Rehabil (2003) 0.85
The molecular genetics of Down syndrome. Mol Genet Med (1992) 0.84
Cardiac and sympathetic activation are reduced in children with Down syndrome and sleep disordered breathing. Sleep (2012) 0.82
Biochemical changes and catecholamine responses in Down's syndrome adolescents in relation to incremental maximal exercise. J Ment Defic Res (1991) 0.79
Impaired peripheral somatosensory function in children with Down syndrome. Neuropediatrics (1995) 0.77